Research Article
The Efficacy and Safety of Chinese Herbal Decoction in Type 2 Diabetes: A 5-Year Retrospective Study
Table 1
Characteristics of study subjects at baseline.
| | | Chinese herbal decoction () |
| | Age (years) | 50.54 ± 12.23 | | Gender (M/F) | 59.86%/40.14% | | Height (m) | 1.68 ± 0.08 | | Weight (kg) | 72.00 ± 12.56 | | Duration of diabetes (month) | 72.96 ± 63.45 | | Duration of treatment (month) | 21.88 ± 18.05 | | Times of therapy () | 11.90 ± 7.77 | | History of hypertension () | 59 (41.55%) | | History of dyslipidemia () | 65 (45.77%) | | History of fatty liver () | 32 (22.54%) | | History of hyperuricemia () | 8 (5.63%) | | Combined with insulin () | 29 (20.42%) | | Combined with metformin () | 37 (26.06%) | | Combined with repaglinide () | 14 (9.86%) | | Combined with gliclazide () | 8 (5.63%) | | Combined with glimepiride () | 5 (3.52%) | | Combined with acarbose () | 24 (16.90%) | | Combined with rosiglitazone () | 4 (2.82%) | | HbA1c (%) | 8.98 ± 2.02 | | FPG (mmol/L) | 9.96 ± 2.94 | | 2hPG (mmol/L) | 14.07 ± 4.90 | | CHO (mmol/L) | 5.43 ± 1.19 | | TG (mmol/L) | 2.71 ± 2.72 | | LDL (mmol/L) | 3.17 ± 0.97 | | HDL (mmol/L) | 1.26 ± 0.43 | | Systolic pressure (mmHg) | 134.71 ± 20.51 | | Diastolic pressure (mmHg) | 83.94 ± 9.68 | | UA (mol/L) | 315.81 ± 118.73 | | ALT (U) | 37.42 ± 47.11 | | AST (U) | 25.58 ± 14.75 |
|
|
Values are expressed as mean ± SD.
|
